Works matching IS 20445385 AND DT 2025

Results: 124
    1

    Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01309-6
    By:
    • Kotmayer, Lili;
    • Kozyra, Emilia J.;
    • Kang, Guolian;
    • Strahm, Brigitte;
    • Yoshimi, Ayami;
    • Sahoo, Sushree S.;
    • Pastor, Victor B.;
    • Attardi, Enrico;
    • Voss, Rebecca;
    • Vinci, Luca;
    • Kaiser, Max;
    • Dworzak, Michael N.;
    • De Moerloose, Barbara;
    • Sukova, Martina;
    • Starý, Jan;
    • Hasle, Henrik;
    • Jahnukainen, Kirsi;
    • Polychronopoulou, Sophia;
    • Kállay, Krisztián;
    • Smith, Owen P.
    Publication type:
    Article
    2

    Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01326-5
    By:
    • Walker, Janek S.;
    • Wenzl, Kerstin;
    • Novak, Joseph P.;
    • Stokes, Matthew E.;
    • Hopper, Melissa A.;
    • Dropik, Abigail R.;
    • Siminski, Miranda S.;
    • Bock, Allison M.;
    • Sarangi, Vivekananda;
    • Ortiz, Maria;
    • Stong, Nicholas;
    • Huang, C. Chris;
    • Maurer, Matthew J.;
    • Link, Brian K.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • King, Rebecca L.;
    • Nowakowski, Grzegorz;
    • Cerhan, James R.
    Publication type:
    Article
    3

    Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01314-9
    By:
    • Dima, Danai;
    • Vazquez-Martinez, Mariola A.;
    • Davis, James A.;
    • Goel, Utkarsh;
    • Afrough, Aimaz;
    • Sannareddy, Aishwarya;
    • Pasvolsky, Oren;
    • Razzo, Beatrice;
    • Banerjee, Rahul;
    • Khouri, Jack;
    • Grajales-Cruz, Ariel;
    • Lieberman-Cribbin, Alex;
    • Rana, Masooma Shifa;
    • Julian, Kelley;
    • DeJarnette, Shaun;
    • Portuguese, Andrew J.;
    • Gaballa, Mahmoud R.;
    • De Avila, Gabriel;
    • Susaniba Adaniya, Sandra;
    • Raza, Shahzad
    Publication type:
    Article
    4
    5
    6

    Comparable outcomes with 14-, 21-, or standard 28-day venetoclax in the first cycle of azacitidine–venetoclax in untreated acute myeloid leukemia: real-world experience from the Hokkaido Leukemia Net.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01324-7
    By:
    • Kanaya, Minoru;
    • Onozawa, Masahiro;
    • Matsukawa, Toshihiro;
    • Miyashita, Naoki;
    • Fujii, Fumiaki;
    • Yoshida, Shota;
    • Nagai, Jun;
    • Aiba, Masayuki;
    • Hidaka, Daisuke;
    • Hashiguchi, Junichi;
    • Senjo, Hajime;
    • Igarashi, Tetsuyuki;
    • Chiba, Masahiro;
    • Yamamoto, Satoshi;
    • Shimizu, Taku;
    • Ishio, Takashi;
    • Yokoyama, Shota;
    • Ebata, Ko;
    • Iyama, Satoshi;
    • Oyake, Tatsuo
    Publication type:
    Article
    7

    Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detection.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01322-9
    By:
    • Atallah-Yunes, Suheil Albert;
    • Rees, Matthew J.;
    • Mwangi, Raphael;
    • Kuchler, Robyn L.;
    • Alnughmush, Ahmed;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Wang, Yucai;
    • Villasboas Bisneto, Jose C.;
    • Feldman, Andrew L.;
    • Maurer, Matthew J.;
    • Cerhan, James R.;
    • Ansell, Stephen M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    8
    9
    10

    Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01321-w
    By:
    • Einarsdottir, Sigrun;
    • Lobaugh, Stephanie;
    • Luan, Danny;
    • Gomez-Llobell, Marina;
    • Subramanian, Padmapriya;
    • Devlin, Sean;
    • Chung, David;
    • Dahi, Parastoo B.;
    • Falchi, Lorenzo;
    • Giralt, Sergio;
    • Landau, Heather;
    • Lesokhin, Alexander M.;
    • Lin, Richard;
    • Lue, Jennifer;
    • Mailankody, Sham;
    • Palomba, M. Lia;
    • Park, Jae H.;
    • Salles, Gilles;
    • Scordo, Michael;
    • Escribano-Serrat, Silvia
    Publication type:
    Article
    11
    12
    13

    Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01314-9
    By:
    • Dima, Danai;
    • Vazquez-Martinez, Mariola A.;
    • Davis, James A.;
    • Goel, Utkarsh;
    • Afrough, Aimaz;
    • Sannareddy, Aishwarya;
    • Pasvolsky, Oren;
    • Razzo, Beatrice;
    • Banerjee, Rahul;
    • Khouri, Jack;
    • Grajales-Cruz, Ariel;
    • Lieberman-Cribbin, Alex;
    • Rana, Masooma Shifa;
    • Julian, Kelley;
    • DeJarnette, Shaun;
    • Portuguese, Andrew J.;
    • Gaballa, Mahmoud R.;
    • De Avila, Gabriel;
    • Susaniba Adaniya, Sandra;
    • Raza, Shahzad
    Publication type:
    Article
    14

    Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01318-5
    By:
    • St-Pierre, Frederique;
    • Bhatta, Subodh;
    • Doukas, Peter G.;
    • Jenkin, Madeline;
    • Annunzio, Kaitlin;
    • Rojek, Alexandra E.;
    • Gibson, Alyssa;
    • Tiger, Yun Kyoung;
    • McCall, Brittany;
    • Alhamad, Khaled;
    • Hansen, Alec;
    • Alderuccio, Juan P.;
    • Adewale, Olutobi;
    • Patel, Keem;
    • Trabolsi, Asaad;
    • Lossos, Izidore S.;
    • Fitzgerald, Lindsey;
    • Ollila, Thomas A.;
    • Matasar, Matthew J.;
    • Kline, Justin
    Publication type:
    Article
    15

    Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working Group.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01286-w
    By:
    • Lu, Xinyan;
    • Andersen, Erica F.;
    • Banerjee, Rahul;
    • Eno, Celeste C.;
    • Gonzales, Patrick R.;
    • Kumar, Shaji;
    • Lager, Angela M.;
    • Miron, Patricia M.;
    • Pugh, Trevor;
    • Quintero-Rivera, Fabiola;
    • Thurston, Virginia C.;
    • Wolff, Daynna J.;
    • Zhao, Jian;
    • Fonseca, Rafael;
    • Baughn, Linda B.
    Publication type:
    Article
    16
    17
    18
    19

    Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01315-8
    By:
    • Gagelmann, Nico;
    • Witte, Moniek de;
    • Peczynski, Christophe;
    • Boreland, William;
    • Broers, Annoek E. C.;
    • Jost, Edgar;
    • Kulagin, Alexander;
    • Esquirol, Albert;
    • Sica, Simona;
    • Kuball, Jürgen;
    • Errico, Gerardo;
    • Bethge, Wolfgang;
    • Maertens, Johan;
    • Stölzel, Friedrich;
    • Forcade, Edouard;
    • Collin, Matthew;
    • Parma, Matteo;
    • Choi, Goda;
    • Kröger, Nicolaus;
    • Di Chio, Maria Chiara
    Publication type:
    Article
    20
    21
    22
    23
    24
    25

    Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01310-z
    By:
    • Parrondo, Ricardo D.;
    • Das, Saurav;
    • Sledge, Hanna;
    • Bergsagel, Leif;
    • Fonseca, Rafael;
    • Leung, Nelson;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Elliott, Jamie;
    • Fernandez, Andre;
    • Flott, Caitlin;
    • Chanan-Khan, Asher A.;
    • Roy, Vivek;
    • Ailawadhi, Sikander
    Publication type:
    Article
    26

    Disease characteristics and monitoring of IDH1/IDH2-mutated acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01304-x
    By:
    • Dantec, Mélinda;
    • Dufossé, Maxime;
    • Boudry, Augustin;
    • Fournier, Elise;
    • Goursaud, Laure;
    • Lebon, Delphine;
    • Bories, Claire;
    • Plantier, Isabelle;
    • Tricot, Sabine;
    • Daniel, Adrien;
    • Willaume, Alexandre;
    • Coiteux, Valérie;
    • Berthon, Céline;
    • Marolleau, Jean-Pierre;
    • Preudhomme, Claude;
    • Duployez, Nicolas;
    • Fenwarth, Laurène
    Publication type:
    Article
    27
    28
    29

    Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01279-9
    By:
    • Narula, Gaurav;
    • Keerthivasagam, Swaminathan;
    • Jain, Hasmukh;
    • Punatar, Sachin;
    • Chichra, Akanksha;
    • Dhamne, Chetan;
    • Tembhare, Prashant;
    • Subramanian, Papagudi Ganesan;
    • Patkar, Nikhil;
    • Poojary, Minal;
    • Gokarn, Anant;
    • Mirgh, Sumeet;
    • Jindal, Nishant;
    • Nisar, Albeena;
    • Pandit, Deepali;
    • Pandit, Khushali;
    • Dwivedi, Alka;
    • Karulkar, Atharva;
    • Jaiswal, Ankesh Kumar;
    • Khan, Aalia
    Publication type:
    Article
    30
    31

    Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01287-9
    By:
    • Ni, Sao-Chih;
    • Yao, Chi-Yuan;
    • Tsai, Xavier Cheng-Hong;
    • Lo, Min-Yen;
    • Chen, Chien-Yuan;
    • Lee, Wan-Hsuan;
    • Lin, Chien-Chin;
    • Kuo, Yuan-Yeh;
    • Peng, Yen-Ling;
    • Tseng, Mei-Hsuan;
    • Wu, Yu-Sin;
    • Liu, Ming-Chih;
    • Lin, Liang-In;
    • Chuang, Ming-Kai;
    • Ko, Bor-Sheng;
    • Yao, Ming;
    • Tang, Jih-Luh;
    • Tien, Feng-Ming;
    • Chou, Wen-Chien;
    • Hou, Hsin-An
    Publication type:
    Article
    32
    33

    Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01298-6
    By:
    • Jimenez-Vicente, Carlos;
    • Cardus, Aina;
    • Castaño-Diez, Sandra;
    • Ramil, Guillermo;
    • Garcia-Avila, Sara;
    • Gomez-Perez, Lucia;
    • Esteban, Daniel;
    • Arribas, Iago;
    • Sturla, Antonella Lucia;
    • Lopez-Guerra, Monica;
    • Martinez-Roca, Alexandra;
    • Cortes-Bullich, Albert;
    • Perez-Valencia, Amanda Isabel;
    • Zugasti, Ines;
    • Monge, Ines;
    • Carcelero, Esther;
    • Vall-Llovera, Ferran;
    • Vives, Susana;
    • Sierra, Jorge;
    • Nomdedeu, Josep
    Publication type:
    Article
    34
    35

    Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01297-7
    By:
    • Pasvolsky, Oren;
    • Dima, Danai;
    • Feng, Lei;
    • Dong, Wenli;
    • Richards, Tiffany;
    • Davis, James A.;
    • Afrough, Aimaz;
    • Vazquez-Martinez, Mariola;
    • Sannareddy, Aishwarya;
    • Goel, Utkarsh;
    • Banerjee, Rahul;
    • Khouri, Jack;
    • Cervoni, Frances;
    • Gaballa, Mahmoud R.;
    • Lieberman-Cribbin, Alex;
    • Rana, Masooma Shifa;
    • Julian, Kelley;
    • Ferreri, Christopher J.;
    • Shune, Leyla;
    • DeJarnette, Shaun
    Publication type:
    Article
    36
    37
    38
    39
    40

    CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01284-y
    By:
    • Giorgetti, Giulia;
    • Maroto-Martin, Elena;
    • Soncini, Debora;
    • Fenoglio, Daniela;
    • Becherini, Pamela;
    • Benzi, Andrea;
    • Ravera, Silvia;
    • Traverso, Isabella;
    • Ladisa, Francesco;
    • Lai, Francesco;
    • Rivoli, Giulia;
    • Truffelli, Dario;
    • Nahimana, Aimable;
    • Cagnetta, Antonia;
    • Guolo, Fabio;
    • Uras, Chiara R. M.;
    • Schavgoulidze, Anaïs;
    • Fong Ng, Jessica;
    • Nencioni, Alessio;
    • Bruzzone, Santina
    Publication type:
    Article
    41

    Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01291-z
    By:
    • de Groen, Ruben A. L.;
    • de Groot, Fleur A.;
    • Böhringer, Stefan;
    • Kret, Esther J.;
    • de Haan, Lorraine M.;
    • Noordenbos, Troy;
    • Blommers, Susan;
    • Jansen, Romée E. W.;
    • van Wezel, Tom;
    • van Eijk, Ronald;
    • Raghoo, Richard;
    • Ruano, Dina;
    • Boome, Liane te;
    • Terpstra, Valeska;
    • Levenga, Henriette;
    • Ahsmann, Els;
    • Posthuma, Eduardus F. M.;
    • Focke-Snieders, Isabelle;
    • Hardi, Lizan;
    • den Hartog, Wietske C. E.
    Publication type:
    Article
    42
    43
    44
    45

    Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01279-9
    By:
    • Narula, Gaurav;
    • Keerthivasagam, Swaminathan;
    • Jain, Hasmukh;
    • Punatar, Sachin;
    • Chichra, Akanksha;
    • Dhamne, Chetan;
    • Tembhare, Prashant;
    • Subramanian, Papagudi Ganesan;
    • Patkar, Nikhil;
    • Poojary, Minal;
    • Gokarn, Anant;
    • Mirgh, Sumeet;
    • Jindal, Nishant;
    • Nisar, Albeena;
    • Pandit, Deepali;
    • Pandit, Khushali;
    • Dwivedi, Alka;
    • Karulkar, Atharva;
    • Jaiswal, Ankesh Kumar;
    • Khan, Aalia
    Publication type:
    Article
    46

    Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01272-2
    By:
    • Cirstea, Diana;
    • Shome, Rajib;
    • Samur, Mehmet;
    • Talluri, Srikanth;
    • Connolly, Joseph J.;
    • Wright, Alexandra Jean;
    • Duvallet, Emilie;
    • Joyce, Amanda N. R.;
    • Lively, Kathleen;
    • Basinsky, Gina;
    • Yee, Andrew J.;
    • Chase, Cristiana Costa;
    • Malek, Ehsan;
    • Niesvizky, Ruben;
    • Richardson, Paul G.;
    • Raje, Noopur S.
    Publication type:
    Article
    47

    Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01266-0
    By:
    • Akiyama, Hiroki;
    • Nishida, Yuki;
    • Chang, Kyung Hee;
    • Bedoy, Andrea D.;
    • Muftuoglu, Muharrem;
    • Ma, Wencai;
    • Basyal, Mahesh;
    • Hirschi, Zoe;
    • Honma, Daisuke;
    • Tsutsumi, Shinji;
    • Wang, Jing;
    • Zhang, Weiguo;
    • Huang, Xuelin;
    • Rampal, Raajit K.;
    • Oluwole, Olalekan O.;
    • Bixby, Dale Lee;
    • Daver, Naval G.;
    • Andreeff, Michael
    Publication type:
    Article
    48

    Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01241-9
    By:
    • Sarkozy, Clémentine;
    • Chartier, Loïc;
    • Ribrag, Vincent;
    • Gressin, Remy;
    • Geisler, Christian H.;
    • Kluin-Nelemans, Hanneke C.;
    • Thieblemont, Catherine;
    • Morschhauser, Franck;
    • Lemonnier, François;
    • Safar, Violaine;
    • Tessoulin, Benoît;
    • Oberic, Lucie;
    • Damaj, Ghandi;
    • Ghesquières, Hervé;
    • Bouabdallah, Krimo;
    • Casasnovas, René Olivier;
    • Houot, Roch;
    • Klapper, Wolfram;
    • Burroni, Barbara;
    • Pott, Christiane
    Publication type:
    Article
    49

    Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01282-0
    By:
    • Mohan, Meera;
    • Szabo, Aniko;
    • Cheruvalath, Heloise;
    • Clennon, Anna;
    • Bhatlapenumarthi, Vineel;
    • Patwari, Anannya;
    • Balev, Metodi;
    • Bhutani, Divaya;
    • Shrestha, Asis;
    • Thanendrarajan, Sharmilan;
    • Dhakal, Binod;
    • Zangari, Maurizio;
    • Trikannad, Anup;
    • Vellanki, Sruthi;
    • Al-Hadidi, Samer;
    • Lentzsch, Suzanne;
    • van Rhee, Frits;
    • Bag, Aishee;
    • D'Souza, Anita;
    • Shah, Nishi
    Publication type:
    Article
    50